RxDoctor Payments Data

Max Seaton, MD

Surgical Oncology · Spokane Valley, WANPI 1184980260

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,000 of the $9,296 with a category attached, or 64.5%. Intuitive Surgical accounts for 76.1% of it on its own, with 50 other manufacturers making up the rest. Reporting peaked in 2022 at $7,643 and has fallen 93.6% since, to $486 in 2025.

$9,296in general payments, 2019–2025

Across 112 payments — averaging $83.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Johnson & Johnson$204
  • AstraZeneca$127
  • Lilly USA, LLC$118
  • Novartis$108
  • Genentech USA, Inc.$105
  • plus $2K from 45 others

What the payments were for

  • Travel & lodging$1,05911%
  • Food & beverage$2,23724%
  • Education$6,00065%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,296 in reported general payments places this provider in the 80th percentile of 31 surgical oncology providers in Washington.

See all surgical oncology providers in Washington

Medicare billing

Part B allowed, 2024
$179,334
Medicare patients
178
Services billed
3,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl37$186
LoperamideLoperamide Hcl16$129

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Spokane Valley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →